Alport syndrome (AS) is a clinically heterogeneous nephropathy caused by pathogenic variants in collagen IV genes (COL4A3, COL4A4, COL4A5) with a prevalence of 1:5.000 [1]. This evidence concerns the gene COL4A4 and kidney disorder.